Skip to main content
Toggle navigation
Login
Home
Back
Favorite
0
Like
Facebook
Tweet
Session VI: Immune Checkpoint Inhibitors for NSCLC
Debate: How to Handle PD-L1 > 50% - Use pembrolizumab + Histology Specific Chemo
Saturday, October 15, 2022
9:15 AM – 9:25 AM
Debate Speaker(s)
Leena Gandhi, MD, PhD
Harvard Medical School/Dana-Farber Cancer Institute
